Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
Part of paid clinical trials in Galveston, Texas.
- Sponsor
- The University of Texas Medical Branch, Galveston
- Study ID
- NCT05672927
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- HPV Infection
- Human Papillomavirus
- Immunization
Eligibility Criteria
- Sex
- FEMALE
- Age
- 27 Years - 45 Years
- Healthy Volunteers
- Accepted
Interventions
- 9-valent HPV vaccine, 2 doses alternate timing — BIOLOGICALEvaluate 2 doses of the 9-valent HPV vaccine across a 12-month period following the 1st dose among 27-45-year-old females.
- 9-valent HPV vaccine, 3 doses standard timing — BIOLOGICALThis will be the comparison group for the 2-dose group.
Study Details
The goal of this clinical trial is to compare a 2-dose and 3-dose series of 9vHPV vaccine among 27-45-year-old females to assess if 2 doses elicit a noninferior immune response. Participants will be randomized 1:1 to either the 2-dose group or the 3-dose group and asked to provide 4 blood samples over a period of 12 months. All 2-dose participants will be offered a 3rd dose after the final blood draw,12 months after their initial vaccination.
Key Dates
- Start date
- Jan 18, 2023
- Status verified
- Oct 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 618 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Females, 3-dose standardThree doses of the 9-valent HPV vaccine to be administered to the comparison group (27-45 years of age) at 0, 2, and 6 months.
- Experimental: Females, 2-dose alternativeTwo doses of the 9-valent HPV vaccine to be administered to the experimental group (27-45 years of age) at 0 and 6 months. Additional HPV vaccine dose will be offered after final blood draw at 12 months.
Primary Outcome Measure
Short-term human papillomavirus (HPV) type-specific antibody response for type HPV-6 [ Time Frame: Month 1 ]
Central Contacts
- Abbey B Berenson, MD, PhD409-772-2417
- Rosalina M Trujillo409-747-5594
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Texas Medical Branch | Galveston | Texas | 77555 |
Find similar trials in Galveston, TX
By research site
Related Studies
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)PHASE2 · Recruiting · Frantz Viral Therapeutics, LLC · Fort Myers, Florida
- Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- Influenza Immunization in Adults Over Age 75Recruiting · Johns Hopkins University · Baltimore, Maryland
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland